<- Go Home
Avalon GloboCare Corp.
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States. The company focuses to develop diagnostics and clinical laboratory services through ownership acquisition or license rights in precision diagnostic assets, genetic testing and clinical laboratory companies through joint ventures, and share ownership structures or distribution rights. The company was founded in 2016 and is headquartered in Freehold, New Jersey.
Market Cap
$2.7M
Volume
127.1K
Cash and Equivalents
$1.0M
EBITDA
-$13.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$9.4M
Profit Margin
112.38%
52 Week High
$21.60
52 Week Low
$2.11
Dividend
N/A
Price / Book Value
-0.18
Price / Earnings
-0.13
Price / Tangible Book Value
-0.18
Enterprise Value
$30.4M
Enterprise Value / EBITDA
-2.31
Operating Income
-$13.4M
Return on Equity
132.59%
Return on Assets
-33.89
Cash and Short Term Investments
$1.0M
Debt
$8.7M
Equity
$5.4M
Revenue
-$8.3M
Unlevered FCF
-$6.4M
Sector
Real Estate Management and Development
Category
N/A